1. Home
  2. ASMB vs SFWL Comparison

ASMB vs SFWL Comparison

Compare ASMB & SFWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$34.75

Market Cap

553.6M

Sector

Health Care

ML Signal

HOLD

Logo Shengfeng Development Limited

SFWL

Shengfeng Development Limited

HOLD

Current Price

$1.00

Market Cap

78.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
SFWL
Founded
2005
2001
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trucking Freight/Courier Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
553.6M
78.4M
IPO Year
2010
2023

Fundamental Metrics

Financial Performance
Metric
ASMB
SFWL
Price
$34.75
$1.00
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$43.40
N/A
AVG Volume (30 Days)
115.0K
90.8K
Earning Date
11-10-2025
08-27-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
31.68
EPS
N/A
0.14
Revenue
$37,191,000.00
$540,461,000.00
Revenue This Year
$42.01
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$7.05
Revenue Growth
31.30
21.10
52 Week Low
$7.75
$0.56
52 Week High
$39.71
$1.29

Technical Indicators

Market Signals
Indicator
ASMB
SFWL
Relative Strength Index (RSI) 52.92 55.51
Support Level $32.25 $0.56
Resistance Level $36.92 $1.18
Average True Range (ATR) 1.68 0.09
MACD -0.47 0.02
Stochastic Oscillator 41.71 70.76

Price Performance

Historical Comparison
ASMB
SFWL

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About SFWL Shengfeng Development Limited

Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services.

Share on Social Networks: